- Case report
- Open Access
- Open Peer Review
Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report
BMC Medical Genetics volume 20, Article number: 12 (2019)
Rubinstein-Taybi syndrome (RSTS) Type 1 (OMIM 180849) is characterized by three main features: intellectual disability; broad and frequently angulated thumbs and halluces; and characteristic facial dysmorphism.
We report on a Saudi boy with RSTS Type 1 and the following distinct features: a midline notch of the upper lip, a bifid tip of the tongue, a midline groove of the lower lip, plump fingers with broad / flat fingertips, and brachydactyly. The child was found to be heterozygous in the CREBBP gene for a sequence variant designated c.4963del, which is predicted to result in premature protein termination p.Leu1655Cysfs*89. The child and his father were also found to be heterozygous in the EP300 gene for a sequence variant designated c.586A > G, which is predicted to result in the amino-acid substitution p.Ile196Val.
Our report expands the clinical spectrum of RSTS to include several distinct facial and limb features. The variant of the CREBBP gene is known to be causative of RSTS Type 1. The variant in the EP300 gene is benign since the father carried the same variant and exhibited no abnormalities. However, functional studies are required to investigate if this benign EP300 variant influences the phenotype in the presence of disease-causing CREBBP gene mutations.
There are two types of Rubinstein-Taybi syndrome (RSTS): Type 1, which is caused by mutations of the CREBBP gene; and Type 2, which is caused by mutations of the EP300 gene. Both types are autosomal dominant. Clinically, the mutations are almost always seen as de novo .
RSTS Type 1 (OMIM 180849) is characterized by three main features: intellectual disability; broad and frequently angulated thumbs and halluces; and characteristic facial dysmorphism, namely highly-arched eyebrows, down-slanting palpebral fissures, a broad nasal bridge, a columella hanging below the alae nasi; a thin upper lip, pouting of the lower lip, and mild micrognathia. Several other variable features have also been described, such as cardiac defects, a highly-arched palate with or without a bifid uvula, low-set posteriorly-rotated ears, patellar dislocation, reduced immunity, and undescended testes. Furthermore, patients have an increased risk of developing tumors, especially those of the nervous system [1,2,3]. RSTS Type 2 (OMIM 613684) has features similar to those of Type 1, although the features tend to be milder. Nonetheless, each type exhibits specific clinical features [1,2,3,4,5,6,7,8,9,10,11,12,13]; and these genotype-phenotype correlations are summarized in Table 1.
In this paper, we report on a Saudi boy with RSTS Type 1 and the following distinct features: a midline notch of the upper lip, a bifid tip of the tongue, a midline groove of the lower lip, plump fingers with broad / flat fingertips, and brachydactyly.
A 4-year old Saudi boy presented to the Hand Clinic for surgical correction of his angulated thumbs. He was an only child of non-consanguineous parents. He was born vaginally at term after an uneventful pregnancy. The birth weight and length were at the 30th centile. Family history was unremarkable. The patient had all the hallmark features of RSTS Type 1 including: intellectual disability, typical facial dysmorphism (highly-arched eyebrows, down-slanted palpebral fissures, a broad nasal bridge, a columella hanging below the alae nasi, low-set posteriorly-rotated ears, a thin upper lip, pouting of the lower lip, a highly-arched palate, and mild micrognathia), broad / flat/ angulated thumbs, broad big toes, and overlapping post-axial toes (Figs. 1, 2, 3 and 4). The child also had the following distinct features: a midline notch of the upper lip, a bifid tip of the tongue, a midline groove of the lower lip, plump fingers with broad / flat fingertips, and brachydactyly (Figs. 1b, 2, 4). The child had a history of cardiac surgery (correction of an atrial septal defect and repair of hemi-anomalous pulmonary venous drainage) as well as orchiopexy (for an undescended left testis). Full systemic examination and radiological investigations did not reveal any other defects. Both parents had no abnormalities.
After informed consent was obtained, genomic DNA was extracted from the peripheral blood of the child and both parents. For testing, a combination of Next Generation Sequencing (NGS) and Sanger Sequencing was used to cover the full coding regions of the tested genes plus 20 bases of the non-coding DNA flanking each exon. The most important two syndromes with features overlapping with those of RSTS are the Cornelia de Lang (OMIM12247) and Floating-Harbor (OMIM 136140) syndromes [14, 15]. Hence, all the genes known to cause RSTS, Cornelia de Lang syndrome, and the Floating-Harbor syndrome (see Table 2) were sequenced. The sequences were then aligned and compared with reference sequences. All differences from the reference sequences (sequence variants) were assigned to one of the five interpretation categories as per ACMG guidelines .
The child was found to be heterozygous in the CREBBP gene for a sequence variant designated c.4963del, which is predicted to result in premature protein termination p.Leu1655Cysfs*89. This variant has been reported to be causative of RSTS Type 1 . The variant was not detected in the parents (Fig. 5a), which indicates that it is a de novo event. According to the criteria of the ACMG, this variant is classified as pathogenic.
The child and his father were also found to be heterozygous in the EP300 gene for a sequence variant designated c.586A > G, which is predicted to result in the amino-acid substitution p.Ile196Val (Fig. 5b). This variant appears to be rare in large population databases of genetic variations (http://exac.broadinstitute.org/variant/22-41513682-A-G). The amino-acid residue p.Ile196 of the EP300 protein has been highly conserved during evolution. The variant is predicted by SIFT, Polyphen-2, and Mutation Taster to be benign. According to Clinvar, the variant has been designated of uncertain significance by one submitter and likely benign by another submitter (https://www.ncbi.nlm.nih.gov/clinvar/variation/158567/). According to the criteria of the ACMG, this variant is classified as likely benign.
Discussion and conclusions
Our report expands the clinical spectrum of RSTS to include several distinct facial and limb features.
Three unique oral features were seen in the midline of our patient. The midline notch of the upper lip may be considered a microform median cleft of the upper lip. Patients with RSTS frequently have a highly arched palate and occasionally a bifid uvula. However, a median upper lip cleft has not been previously described . Similarly, the median groove of the lower lip has not been previously described in RSTS. However, bifidity of the tip of the tongue has been previously described, but is a rare feature in RSTS .
The other distinct features seen in our patient were plump fingers with broad / flat fingertips, as well as brachydactyly of all the fingers and the second toes. Our review of the literature did not reveal any reported case of RSTS with these features. It should be noted that RSTS patients frequently present with brachydactyly of the distal phalanx of the thumbs (also known as brachy-telephalangism) . Furthermore, short first metatarsals and brachydactyly of the 5th toes have been described in RSTS Type 2 (see Table 1) .
The most important two syndromes with overlapping features with RSTS are the Cornelia de Lang and Floating-Harbor syndromes [14, 15]. All 3 syndromes share many of the facial features as well as the intellectual disability. Characteristic features of Cornelia de Lang syndrome include: synophrys (the two eyebrows meeting in the middle above the bridge of the nose), common occurrence of ophthalmic features (such as nystagmus and myopia), gastrointestinal reflux, and hearing loss. Characteristic features of the Floating-Harbor syndrome include proportionate short stature, delayed speech development, and delayed bone age. However, it is frequently difficult to differentiate between the Floating-Harbor syndrome and RSTS clinically. This is not surprising since the causative gene of the former syndrome (the SRCAP gene) encodes the SNF2-related CREBBP activator protein . Our patient did not have any of the characteristic features of the Cornelia de Lang and Floating-Harbor syndromes, and the patient tested wild-type to their causative genes (See Table 2).
Woods et al.  reported on a patient with RSTS Type 2 and a novel EP300 frame shift mutation with features that overlap those of the Cornelia de Lange syndrome (OMIM 122470) including the characteristic synophrys. This was thought to be important for the clinician since intellectual disability, arching of the eyebrows, and hirsutism are features of both RSTS and Cornelia de Lang syndromes. Similarly, a microform median upper lip cleft, a bifid tongue, and brachydactyly are characteristic features of oro-facio-digital syndrome Type 1 (OFD1, OMIM 311200) . Hence, our case shows that patients with RSTS Type 1 may have features that overlap with those of OFD1. However, OFD1 patients have several other differentiating facial and systemic features such as sparse hair, alopecia, milia, lingual hamartomas, cerebral/cerebellar abnormalities, and polycystic kidneys. Knowledge of these overlapping features is also important for clinical identification, especially in cases of RSTS with a mild phenotype (also known as the incomplete RSTS) .
The truncating mutation in the CREBBP gene of our patient was within the HAT (Histone Acetyl Transferase) domain. Most previously reported truncating and missense mutations of the CREBBP gene were clustered within the HAT domain . The HAT domain promotes histone acetylation which affects the transcriptional availability of chromatin .
Another interesting finding in our patient was the presence of the benign variant in the EP300 gene. The father carried the same variant and exhibited no abnormalities. However, functional studies are required to investigate whether this variant affects the phenotype in the presence of CREBBP gene mutations. This is theoretically possible because the encoded proteins of the two genes have homologous binding sites for several transcription factors .
American College of Medical Genetics and Genomics
Cyclic AMP- Response Elements-Binding Protein
E1A-Binding Protein 300
Histone acetyl transferase
Next generation sequencing
Oral-facial digital syndrome Type 1
Sorting intolerant from tolerant
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin
Roelfsema JH, White SJ, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen G-JB, Breuning MH, Hennekam RC, Peters DJM. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet. 2005;76:572–80.
Bartsch O, Locher K, Meinecke P, Kress W, Seemanová E, Wagner A, Ostermann K, Rödel G. Molecular studies in 10 cases of Rubinstein-Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. J Med Genet. 2002;39(7):496–501.
Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet. 1995;56:112–5.
Zimmermann N, Acosta AMBF, Kohlhase J, Bartsch O. Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome. Europ J Hum Genet. 2007;15:837–42.
Hamilton MJ, Newbury-Ecob R, Holder-Espinasse M, Yau S, Lillis S, Hurst JA, Clement E, Reardon W, Joss S, Hobson E, Blyth M, Al-Shehhi M, Lynch SA, DDD study, Suri M. Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum. Clin Dysmorph. 2016;25:135–47.
Foley P, Bunyan D, Stratton J, Dillon M, Lynch SA. Further case of Rubinstein-Taybi syndrome due to a deletion in EP300. Am J Med Genet. 2009;149A:997–1000.
Bentivegna A, Milani D, Gervasini C, Castronovo P, Mottadelli F, Manzini S, Colapietro P, Giordano L, Atzeri F, Divizia MT, Uzielli ML, Neri G, Bedeschi MF, Faravelli F, Selicorni A, Larizza L. Rubinstein-Taybi syndrome: spectrum of CREBBP mutations in Italian patients. BMC Med Genet. 2006;7:77. https://doi.org/10.1186/1471-2350-7-77.
Hennekam RC, Van Doorne JM. Oral aspects of Rubinstein-Taybi syndrome. Am J Med Genet Suppl. 1990;6:42–7.
Fergelot P, Van Belzen M, Van Gils J, Afenjar A, Armour CM, Arveiler B, Beets L, Burglen L, Busa T, Collet M, Deforges J, de Vries BB, Dominguez Garrido E, Dorison N, Dupont J, Francannet C, Garciá-Minaúr S, Gabau Vila E, Gebre-Medhin S, Gener Querol B, Geneviève D, Gérard M, Gervasini CG, Goldenberg A, Josifova D, Lachlan K, Maas S, Maranda B, Moilanen JS, Nordgren A, Parent P, Rankin J, Reardon W, Rio M, Roume J, Shaw A, Smigiel R, Sojo A, Solomon B, Stembalska A, Stumpel C, Suarez F, Terhal P, Thomas S, Touraine R, Verloes A, Vincent-Delorme C, Wincent J, Peters DJ, Bartsch O, Larizza L, Lacombe D, Hennekam RC. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. Am J Med Genet A. 2016;170A(12):3069–82.
Schorry EK, Keddache M, Lanphear N, Rubinstein JH, Srodulski S, Fletcher D, Blough-Pfau RI, Grabowski GA. Genotype-phenotype correlations in Rubinstein-Taybi syndrome. Am J Med Genet A. 2008;146A(19):2512–9.
Bartsch O, Kress W, Kempf O, Lechno S, Haaf T, Zechner U. Inheritance and variable expression in Rubinstein-Taybi syndrome. Am J Med Genet. 2010;152A:2254–61.
Bartsch O, Labonte J, Albrecht B, Wieczorek D, Lechno S, Zechner U, Haaf T. Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome. Am J Med Genet. 2010;152A:181–4.
Naimi DR, Munoz J, Rubinstein J, Hostoffer RW Jr. Rubinstein-Taybi syndrome: an immune deficiency as a cause for recurrent infections. Allergy Asthma Proc. 2006;27:281–4.
Boyle MI, Jespersgaard C, Brondum-Nielsen K, Bisgaard A-M, Tumer Z. Cornelia de Lange syndrome. Clin Genet. 2015;88:1–12.
Hood RL, Lines MA, Nikkel SM, Schwartzentruber J, Beaulieu C, Nowaczyk MJM, Allanson J, Kim CA, Wieczorek D, Moilanen JS, Lacombe D, Gillessen-Kaesbach G, Whiteford ML, Quaio CR, Gomy I, Bertola DR, Albrecht B, Platzer K, McGillivray G, Zou R, McLeod DR, Chudley AE, Chodirker BN, Marcadier J, FORGE Canada Consortium, Majewski J, Bulman DE, White SM, Boycott KM. Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. Am J Hum Genet. 2012;90:308–13.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.
Woods SA, Robinson HB, Kohler LJ, Agamanolis D, Sterbenz G, Khalifa M. Exome sequencing identifies a novel EP300 frame shift mutation in a patient with features that overlap Cornelia de Lange syndrome. Am J Med Genet A. 2014;164A(1):251–8.
AlKattan WM, Al-Qattan MM, Bafaqeeh SA. The pathogenesis of the clinical features of oral-facial-digital syndrome type I. Saudi Med J. 2015;36(11):1277–84.
Bartsch O, Schmidt S, Richter M, Morlot S, Seemanová E, Wiebe G, Rasi S. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet. 2005;117(5):485–93.
Lundblad JR, Kwok RP, Laurance ME, Harter ML, Goodman RH. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature. 1995;374(6517):85–8.
We would like to thank the parents of our patient who agreed to participate in the study.
Availability of data and materials
The datasets used and analyzed in the current study are available from the corresponding author upon request.
Ethics approval and consent to participate
The case report was approved by the Research Committee of the National Hospital of Riyadh, Saudi Arabia (#22–2018), and in compliance with the Declaration of Helsinki principles. Parental consent was obtained on behalf of the child for participation in the study.
Consent for publication
A written consent for publication of clinical data and images was obtained from the parents on behalf of the child.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Al-Qattan, M.M., Jarman, A., Rafique, A. et al. Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report. BMC Med Genet 20, 12 (2019) doi:10.1186/s12881-019-0747-5
- Rubinstein-Taybi syndrome